Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,458,957
  • Shares Outstanding, K 214,786
  • Annual Sales, $ 872,000 K
  • Annual Income, $ -23,550 K
  • EBIT $ 12 M
  • EBITDA $ 16 M
  • 60-Month Beta 1.06
  • Price/Sales 5.01
  • Price/Cash Flow N/A
  • Price/Book 12.08

Options Overview Details

View History
  • Implied Volatility 95.91% ( -15.30%)
  • Historical Volatility 91.42%
  • IV Percentile 86%
  • IV Rank 61.08%
  • IV High 129.37% on 08/05/24
  • IV Low 43.41% on 12/19/23
  • Put/Call Vol Ratio 0.86
  • Today's Volume 162,697
  • Volume Avg (30-Day) 40,799
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 342,863
  • Open Int (30-Day) 282,275

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.05
  • Number of Estimates 6
  • High Estimate 0.07
  • Low Estimate 0.04
  • Prior Year 0.01
  • Growth Rate Est. (year over year) +400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.36 +18.89%
on 10/11/24
23.74 -13.06%
on 10/22/24
+2.98 (+16.87%)
since 10/04/24
3-Month
13.47 +53.23%
on 09/06/24
23.74 -13.06%
on 10/22/24
+2.80 (+15.70%)
since 08/05/24
52-Week
6.23 +231.30%
on 11/06/23
25.74 -19.81%
on 06/18/24
+14.16 (+218.52%)
since 11/03/23

Most Recent Stories

More News
Could This Magnificent Pharma Stock 10x in the Next 5 Years?

Disrupting pharmacies is just the start for Hims & Hers.

HIMS : 20.64 (-0.58%)
Top 3 Stocks Institutions Are Buying Right Now

Despite the stock market trading at new all-time highs, institutions still find enough reason to buy more enormous stakes in three stocks.

BABA : 99.21 (+0.82%)
NVDA : 139.91 (+2.84%)
HIMS : 20.64 (-0.58%)
ASML : 676.46 (+0.79%)
TSM : 195.76 (+2.19%)
Hims & Hers Stock Dropped: Here's What You Need to Know

The GLP-1 drama continues at Hims & Hers.

CVS : 55.34 (+1.26%)
HIMS : 20.64 (-0.58%)
NVO : 110.13 (+0.37%)
WBA : 9.62 (+3.11%)
Why Hims & Hers' Incredible Growth Will Continue

GLP-1s get all the attention, but Hims & Hers' core business is where the rocket growth is.

HIMS : 20.64 (-0.58%)
Where Does Hims & Hers Stock Go From Here?

Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright?

CVS : 55.34 (+1.26%)
HIMS : 20.64 (-0.58%)
WBA : 9.62 (+3.11%)
2 Incredibly Cheap Growth Stocks to Buy Right Now

Look beyond the stock price at the business when shares are volatile.

HIMS : 20.64 (-0.58%)
UPST : 50.60 (+7.11%)
2 No-Brainer Growth Stocks to Buy With $500 Right Now

Consistently investing even moderate sums can grow your portfolio with time.

SHOP : 79.57 (+1.44%)
HIMS : 20.64 (-0.58%)
What Is Going On With Hims & Hers Stock?

Big GLP-1 news could have an impact.

HIMS : 20.64 (-0.58%)
Top 3 Stocks with Explosive Call Option Activity: What to Watch

Three stocks reported a surge in call option buying recently, showing investors that there could be a path to more upside potential, analysts agree

HIMS : 20.64 (-0.58%)
LLY : 806.06 (-0.01%)
MSCI : 588.32 (-0.17%)
HOOD : 24.96 (+2.63%)
GLD : 253.40 (+0.23%)
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?

There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition to the S&P 600 index alongside double-digit growth.

HIMS : 20.64 (-0.58%)
MSCI : 588.32 (-0.17%)
LLY : 806.06 (-0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 22.72
2nd Resistance Point 22.03
1st Resistance Point 21.40
Last Price 20.64
1st Support Level 20.08
2nd Support Level 19.39
3rd Support Level 18.76

See More

52-Week High 25.74
Last Price 20.64
Fibonacci 61.8% 18.29
Fibonacci 50% 15.98
Fibonacci 38.2% 13.68
52-Week Low 6.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar